Treatment strategy for and clinical results in patients with recurrent esophageal cancer

Hiroshi Saeki, H. Kawaguchi, K. Araki, S. Ohno, K. Sugimachi

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

In the current study, we evaluate the frequency and pattern of recurrence in patients with esophageal cancer. Among 116 patients who had undergone curative resection for esophageal cancer, recurrence was found in 33 (28.4%). The most frequent pattern of recurrence was lymphatic (54.5%), followed by the mixed type (18.2%), hematogenic (12.1%), locoregional (12.1%), and anastomotic (3.0%) patterns. Recurrence was found within 1 year after surgery in 18 (54.5%), within 2 years in 12 (36.4%), and within 3 years in 3 (9.1%). In patients with recurrence, lymph node metastasis and advanced stage were seen more frequently than in those without recurrence. The prognosis for patients with recurrent disease is poor. However, in some cases surgical resection, systemic chemotherapy, hepatic arterial infusion chemotherapy, and local radiation therapy have proven to be effective. The most appropriate therapy should be selected based on the region of extension and patient performance status to provide optimum treatment of recurrent disease.

Original languageEnglish
Pages (from-to)185-190
Number of pages6
JournalNippon Geka Gakkai zasshi
Volume100
Issue number2
Publication statusPublished - Jan 1 1999

Fingerprint

Esophageal Neoplasms
Recurrence
Therapeutics
Drug Therapy
Radiotherapy
Lymph Nodes
Neoplasm Metastasis
Liver

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Saeki, H., Kawaguchi, H., Araki, K., Ohno, S., & Sugimachi, K. (1999). Treatment strategy for and clinical results in patients with recurrent esophageal cancer. Nippon Geka Gakkai zasshi, 100(2), 185-190.

Treatment strategy for and clinical results in patients with recurrent esophageal cancer. / Saeki, Hiroshi; Kawaguchi, H.; Araki, K.; Ohno, S.; Sugimachi, K.

In: Nippon Geka Gakkai zasshi, Vol. 100, No. 2, 01.01.1999, p. 185-190.

Research output: Contribution to journalReview article

Saeki, H, Kawaguchi, H, Araki, K, Ohno, S & Sugimachi, K 1999, 'Treatment strategy for and clinical results in patients with recurrent esophageal cancer', Nippon Geka Gakkai zasshi, vol. 100, no. 2, pp. 185-190.
Saeki H, Kawaguchi H, Araki K, Ohno S, Sugimachi K. Treatment strategy for and clinical results in patients with recurrent esophageal cancer. Nippon Geka Gakkai zasshi. 1999 Jan 1;100(2):185-190.
Saeki, Hiroshi ; Kawaguchi, H. ; Araki, K. ; Ohno, S. ; Sugimachi, K. / Treatment strategy for and clinical results in patients with recurrent esophageal cancer. In: Nippon Geka Gakkai zasshi. 1999 ; Vol. 100, No. 2. pp. 185-190.
@article{11881cc76a004bebac7299953b1f19ee,
title = "Treatment strategy for and clinical results in patients with recurrent esophageal cancer",
abstract = "In the current study, we evaluate the frequency and pattern of recurrence in patients with esophageal cancer. Among 116 patients who had undergone curative resection for esophageal cancer, recurrence was found in 33 (28.4{\%}). The most frequent pattern of recurrence was lymphatic (54.5{\%}), followed by the mixed type (18.2{\%}), hematogenic (12.1{\%}), locoregional (12.1{\%}), and anastomotic (3.0{\%}) patterns. Recurrence was found within 1 year after surgery in 18 (54.5{\%}), within 2 years in 12 (36.4{\%}), and within 3 years in 3 (9.1{\%}). In patients with recurrence, lymph node metastasis and advanced stage were seen more frequently than in those without recurrence. The prognosis for patients with recurrent disease is poor. However, in some cases surgical resection, systemic chemotherapy, hepatic arterial infusion chemotherapy, and local radiation therapy have proven to be effective. The most appropriate therapy should be selected based on the region of extension and patient performance status to provide optimum treatment of recurrent disease.",
author = "Hiroshi Saeki and H. Kawaguchi and K. Araki and S. Ohno and K. Sugimachi",
year = "1999",
month = "1",
day = "1",
language = "English",
volume = "100",
pages = "185--190",
journal = "Nihon Geka Gakkai zasshi",
issn = "0301-4894",
publisher = "Nihon Geka Gakkai",
number = "2",

}

TY - JOUR

T1 - Treatment strategy for and clinical results in patients with recurrent esophageal cancer

AU - Saeki, Hiroshi

AU - Kawaguchi, H.

AU - Araki, K.

AU - Ohno, S.

AU - Sugimachi, K.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - In the current study, we evaluate the frequency and pattern of recurrence in patients with esophageal cancer. Among 116 patients who had undergone curative resection for esophageal cancer, recurrence was found in 33 (28.4%). The most frequent pattern of recurrence was lymphatic (54.5%), followed by the mixed type (18.2%), hematogenic (12.1%), locoregional (12.1%), and anastomotic (3.0%) patterns. Recurrence was found within 1 year after surgery in 18 (54.5%), within 2 years in 12 (36.4%), and within 3 years in 3 (9.1%). In patients with recurrence, lymph node metastasis and advanced stage were seen more frequently than in those without recurrence. The prognosis for patients with recurrent disease is poor. However, in some cases surgical resection, systemic chemotherapy, hepatic arterial infusion chemotherapy, and local radiation therapy have proven to be effective. The most appropriate therapy should be selected based on the region of extension and patient performance status to provide optimum treatment of recurrent disease.

AB - In the current study, we evaluate the frequency and pattern of recurrence in patients with esophageal cancer. Among 116 patients who had undergone curative resection for esophageal cancer, recurrence was found in 33 (28.4%). The most frequent pattern of recurrence was lymphatic (54.5%), followed by the mixed type (18.2%), hematogenic (12.1%), locoregional (12.1%), and anastomotic (3.0%) patterns. Recurrence was found within 1 year after surgery in 18 (54.5%), within 2 years in 12 (36.4%), and within 3 years in 3 (9.1%). In patients with recurrence, lymph node metastasis and advanced stage were seen more frequently than in those without recurrence. The prognosis for patients with recurrent disease is poor. However, in some cases surgical resection, systemic chemotherapy, hepatic arterial infusion chemotherapy, and local radiation therapy have proven to be effective. The most appropriate therapy should be selected based on the region of extension and patient performance status to provide optimum treatment of recurrent disease.

UR - http://www.scopus.com/inward/record.url?scp=0033070562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033070562&partnerID=8YFLogxK

M3 - Review article

C2 - 10331216

AN - SCOPUS:0033070562

VL - 100

SP - 185

EP - 190

JO - Nihon Geka Gakkai zasshi

JF - Nihon Geka Gakkai zasshi

SN - 0301-4894

IS - 2

ER -